Article
Another Beginning for Cystic Fibrosis Therapy
17 May 2015
Abstract excerpt
Treatments for the fundamental defect in cystic fibrosis are beginning to come to fruition. Cystic fibrosis, an autosomal recessive disease of epithelial chloride transport, can be caused by more than 1000 mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). However, these mutations fall into six functional categories,1 which gives hope that therapies specific to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
